Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
527
mi
from 43215
Charleston, SC
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
527
mi
from 43215
Charleston, SC
Click here to add this to my saved trials
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
524
mi
from 43215
Mount Pleasant, SC
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
524
mi
from 43215
Mount Pleasant, SC
Click here to add this to my saved trials
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
494
mi
from 43215
Murrells Inlet, SC
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
494
mi
from 43215
Murrells Inlet, SC
Click here to add this to my saved trials
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1071
mi
from 43215
Rapid City, SD
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1071
mi
from 43215
Rapid City, SD
Click here to add this to my saved trials
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
239
mi
from 43215
Bristol, TN
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
239
mi
from 43215
Bristol, TN
Click here to add this to my saved trials
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
362
mi
from 43215
Chattanooga, TN
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
362
mi
from 43215
Chattanooga, TN
Click here to add this to my saved trials
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
431
mi
from 43215
Jackson, TN
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
431
mi
from 43215
Jackson, TN
Click here to add this to my saved trials
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
254
mi
from 43215
Johnson City, TN
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
254
mi
from 43215
Johnson City, TN
Click here to add this to my saved trials
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
254
mi
from 43215
Johnson City, TN
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
254
mi
from 43215
Johnson City, TN
Click here to add this to my saved trials
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
237
mi
from 43215
Kingsport, TN
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
237
mi
from 43215
Kingsport, TN
Click here to add this to my saved trials
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
283
mi
from 43215
Knoxville, TN
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
283
mi
from 43215
Knoxville, TN
Click here to add this to my saved trials
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
399
mi
from 43215
McKenzie, TN
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
399
mi
from 43215
McKenzie, TN
Click here to add this to my saved trials
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
331
mi
from 43215
Nashville, TN
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
331
mi
from 43215
Nashville, TN
Click here to add this to my saved trials
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
933
mi
from 43215
Arlington, TX
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
933
mi
from 43215
Arlington, TX
Click here to add this to my saved trials
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
910
mi
from 43215
Dallas, TX
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
910
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1425
mi
from 43215
El Paso, TX
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1425
mi
from 43215
El Paso, TX
Click here to add this to my saved trials
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
996
mi
from 43215
Friendswood, TX
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
996
mi
from 43215
Friendswood, TX
Click here to add this to my saved trials
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
991
mi
from 43215
Houston, TX
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1144
mi
from 43215
San Antonio, TX
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1144
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
993
mi
from 43215
Webster, TX
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
993
mi
from 43215
Webster, TX
Click here to add this to my saved trials
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1515
mi
from 43215
Layton, UT
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1515
mi
from 43215
Layton, UT
Click here to add this to my saved trials
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated:  12/31/1969
5386
mi
from 43215
Buenos Aires,
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated: 12/31/1969
5386
mi
from 43215
Buenos Aires,
Click here to add this to my saved trials
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
970
mi
from 43215
Fort Lauderdale, FL
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
970
mi
from 43215
Fort Lauderdale, FL
Click here to add this to my saved trials
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
683
mi
from 43215
Saint Cloud, MN
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
683
mi
from 43215
Saint Cloud, MN
Click here to add this to my saved trials
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated:  12/31/1969
Research Site
455
mi
from 43215
Margate City, NJ
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated: 12/31/1969
Research Site
455
mi
from 43215
Margate City, NJ
Click here to add this to my saved trials
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
328
mi
from 43215
Washington,
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
328
mi
from 43215
Washington,
Click here to add this to my saved trials
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
482
mi
from 43215
Bronx, NY
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
482
mi
from 43215
Bronx, NY
Click here to add this to my saved trials
Botanical Oil Supplementation in Diabetic and Metabolic Syndrome Subjects
Modulation of Biomarkers and Gene Expression by Botanical Oil Supplementation in Diabetic and Metabolic Syndrome Subjects.
Status: Enrolling
Updated:  12/31/1969
Wake Forest Baptist Medical Center
306
mi
from 43215
Winston-Salem, NC
Botanical Oil Supplementation in Diabetic and Metabolic Syndrome Subjects
Modulation of Biomarkers and Gene Expression by Botanical Oil Supplementation in Diabetic and Metabolic Syndrome Subjects.
Status: Enrolling
Updated: 12/31/1969
Wake Forest Baptist Medical Center
306
mi
from 43215
Winston-Salem, NC
Click here to add this to my saved trials
Miami Healthy Heart Initiative a Behavioral Study on Cardiovascular Risk Factors
Miami Healthy Heart Initiative (MHHI) a Randomized Study of Behavioral Risk Factors for Cardiovascular Disease in Latino and Hispanic Patients With Poorly Controlled Diabetes
Status: Enrolling
Updated:  12/31/1969
University of Miami
992
mi
from 43215
Miami, FL
Miami Healthy Heart Initiative a Behavioral Study on Cardiovascular Risk Factors
Miami Healthy Heart Initiative (MHHI) a Randomized Study of Behavioral Risk Factors for Cardiovascular Disease in Latino and Hispanic Patients With Poorly Controlled Diabetes
Status: Enrolling
Updated: 12/31/1969
University of Miami
992
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Diabetes and Gastric By- Pass
Unraveling the Mechanisms of Rapid Improvement in Diabetes Following Gastric By-Pass Surgery
Status: Enrolling
Updated:  12/31/1969
Clinical and Translational Research Center
910
mi
from 43215
Dallas, TX
Diabetes and Gastric By- Pass
Unraveling the Mechanisms of Rapid Improvement in Diabetes Following Gastric By-Pass Surgery
Status: Enrolling
Updated: 12/31/1969
Clinical and Translational Research Center
910
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Care Guides in the Primary Care Office (Phase II)
Care Guides: Can Trained Laypersons Help Manage Chronic Disease? A Randomized Trial.
Status: Enrolling
Updated:  12/31/1969
Allina Hospitals and Clinics
623
mi
from 43215
Minneapolis, MN
Care Guides in the Primary Care Office (Phase II)
Care Guides: Can Trained Laypersons Help Manage Chronic Disease? A Randomized Trial.
Status: Enrolling
Updated: 12/31/1969
Allina Hospitals and Clinics
623
mi
from 43215
Minneapolis, MN
Click here to add this to my saved trials
To Evaluate if Wide Blood Sugar Fluctuations Lead to Injury of Heart Function and Heart Nerves
Cardiac Autonomic Neuropathy and Myocardial Dysfunction in Type 1 Diabetes
Status: Enrolling
Updated:  12/31/1969
University of Michigan
164
mi
from 43215
Ann Arbor, MI
To Evaluate if Wide Blood Sugar Fluctuations Lead to Injury of Heart Function and Heart Nerves
Cardiac Autonomic Neuropathy and Myocardial Dysfunction in Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
University of Michigan
164
mi
from 43215
Ann Arbor, MI
Click here to add this to my saved trials
Exercise Endothelial Progenitor Cells (EPCs) and Type 2 Diabetes
Exercise Training, CACs, and Vascular Function in Older Veterans With IGT (Impaired Glucose Tolerance)
Status: Enrolling
Updated:  12/31/1969
Baltimore VA Medical Center
343
mi
from 43215
Baltimore, MD
Exercise Endothelial Progenitor Cells (EPCs) and Type 2 Diabetes
Exercise Training, CACs, and Vascular Function in Older Veterans With IGT (Impaired Glucose Tolerance)
Status: Enrolling
Updated: 12/31/1969
Baltimore VA Medical Center
343
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results
A Long-term, Multi-centre, International, Randomised Double-blind, Placebo-controlled Trial to Determine Liraglutide Effects on Cardiovascular Events
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
509
mi
from 43215
Alabaster, AL
Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results
A Long-term, Multi-centre, International, Randomised Double-blind, Placebo-controlled Trial to Determine Liraglutide Effects on Cardiovascular Events
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
509
mi
from 43215
Alabaster, AL
Click here to add this to my saved trials
Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results
A Long-term, Multi-centre, International, Randomised Double-blind, Placebo-controlled Trial to Determine Liraglutide Effects on Cardiovascular Events
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
481
mi
from 43215
Birmingham, AL
Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results
A Long-term, Multi-centre, International, Randomised Double-blind, Placebo-controlled Trial to Determine Liraglutide Effects on Cardiovascular Events
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
481
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results
A Long-term, Multi-centre, International, Randomised Double-blind, Placebo-controlled Trial to Determine Liraglutide Effects on Cardiovascular Events
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
411
mi
from 43215
Huntsville, AL
Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results
A Long-term, Multi-centre, International, Randomised Double-blind, Placebo-controlled Trial to Determine Liraglutide Effects on Cardiovascular Events
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
411
mi
from 43215
Huntsville, AL
Click here to add this to my saved trials
Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results
A Long-term, Multi-centre, International, Randomised Double-blind, Placebo-controlled Trial to Determine Liraglutide Effects on Cardiovascular Events
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
699
mi
from 43215
Mobile, AL
Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results
A Long-term, Multi-centre, International, Randomised Double-blind, Placebo-controlled Trial to Determine Liraglutide Effects on Cardiovascular Events
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
699
mi
from 43215
Mobile, AL
Click here to add this to my saved trials
Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results
A Long-term, Multi-centre, International, Randomised Double-blind, Placebo-controlled Trial to Determine Liraglutide Effects on Cardiovascular Events
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
1657
mi
from 43215
Tempe, AZ
Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results
A Long-term, Multi-centre, International, Randomised Double-blind, Placebo-controlled Trial to Determine Liraglutide Effects on Cardiovascular Events
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1657
mi
from 43215
Tempe, AZ
Click here to add this to my saved trials
Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results
A Long-term, Multi-centre, International, Randomised Double-blind, Placebo-controlled Trial to Determine Liraglutide Effects on Cardiovascular Events
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
623
mi
from 43215
Little Rock, AR
Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results
A Long-term, Multi-centre, International, Randomised Double-blind, Placebo-controlled Trial to Determine Liraglutide Effects on Cardiovascular Events
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
623
mi
from 43215
Little Rock, AR
Click here to add this to my saved trials
Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results
A Long-term, Multi-centre, International, Randomised Double-blind, Placebo-controlled Trial to Determine Liraglutide Effects on Cardiovascular Events
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
1962
mi
from 43215
Anaheim, CA
Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results
A Long-term, Multi-centre, International, Randomised Double-blind, Placebo-controlled Trial to Determine Liraglutide Effects on Cardiovascular Events
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1962
mi
from 43215
Anaheim, CA
Click here to add this to my saved trials
Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results
A Long-term, Multi-centre, International, Randomised Double-blind, Placebo-controlled Trial to Determine Liraglutide Effects on Cardiovascular Events
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
1967
mi
from 43215
Cerritos, CA
Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results
A Long-term, Multi-centre, International, Randomised Double-blind, Placebo-controlled Trial to Determine Liraglutide Effects on Cardiovascular Events
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1967
mi
from 43215
Cerritos, CA
Click here to add this to my saved trials
Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results
A Long-term, Multi-centre, International, Randomised Double-blind, Placebo-controlled Trial to Determine Liraglutide Effects on Cardiovascular Events
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
1936
mi
from 43215
Escondido, CA
Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results
A Long-term, Multi-centre, International, Randomised Double-blind, Placebo-controlled Trial to Determine Liraglutide Effects on Cardiovascular Events
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1936
mi
from 43215
Escondido, CA
Click here to add this to my saved trials
Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results
A Long-term, Multi-centre, International, Randomised Double-blind, Placebo-controlled Trial to Determine Liraglutide Effects on Cardiovascular Events
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
1988
mi
from 43215
Fresno, CA
Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results
A Long-term, Multi-centre, International, Randomised Double-blind, Placebo-controlled Trial to Determine Liraglutide Effects on Cardiovascular Events
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1988
mi
from 43215
Fresno, CA
Click here to add this to my saved trials
Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results
A Long-term, Multi-centre, International, Randomised Double-blind, Placebo-controlled Trial to Determine Liraglutide Effects on Cardiovascular Events
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
1973
mi
from 43215
Los Angeles, CA
Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results
A Long-term, Multi-centre, International, Randomised Double-blind, Placebo-controlled Trial to Determine Liraglutide Effects on Cardiovascular Events
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1973
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results
A Long-term, Multi-centre, International, Randomised Double-blind, Placebo-controlled Trial to Determine Liraglutide Effects on Cardiovascular Events
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
2039
mi
from 43215
Los Banos, CA
Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results
A Long-term, Multi-centre, International, Randomised Double-blind, Placebo-controlled Trial to Determine Liraglutide Effects on Cardiovascular Events
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
2039
mi
from 43215
Los Banos, CA
Click here to add this to my saved trials
Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results
A Long-term, Multi-centre, International, Randomised Double-blind, Placebo-controlled Trial to Determine Liraglutide Effects on Cardiovascular Events
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
1978
mi
from 43215
Mission Hills, CA
Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results
A Long-term, Multi-centre, International, Randomised Double-blind, Placebo-controlled Trial to Determine Liraglutide Effects on Cardiovascular Events
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1978
mi
from 43215
Mission Hills, CA
Click here to add this to my saved trials
Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results
A Long-term, Multi-centre, International, Randomised Double-blind, Placebo-controlled Trial to Determine Liraglutide Effects on Cardiovascular Events
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
1942
mi
from 43215
Montclair, CA
Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results
A Long-term, Multi-centre, International, Randomised Double-blind, Placebo-controlled Trial to Determine Liraglutide Effects on Cardiovascular Events
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1942
mi
from 43215
Montclair, CA
Click here to add this to my saved trials
Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results
A Long-term, Multi-centre, International, Randomised Double-blind, Placebo-controlled Trial to Determine Liraglutide Effects on Cardiovascular Events
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
1951
mi
from 43215
San Diego, CA
Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results
A Long-term, Multi-centre, International, Randomised Double-blind, Placebo-controlled Trial to Determine Liraglutide Effects on Cardiovascular Events
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1951
mi
from 43215
San Diego, CA
Click here to add this to my saved trials
Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results
A Long-term, Multi-centre, International, Randomised Double-blind, Placebo-controlled Trial to Determine Liraglutide Effects on Cardiovascular Events
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
1957
mi
from 43215
Tustin, CA
Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results
A Long-term, Multi-centre, International, Randomised Double-blind, Placebo-controlled Trial to Determine Liraglutide Effects on Cardiovascular Events
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1957
mi
from 43215
Tustin, CA
Click here to add this to my saved trials
Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results
A Long-term, Multi-centre, International, Randomised Double-blind, Placebo-controlled Trial to Determine Liraglutide Effects on Cardiovascular Events
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
2084
mi
from 43215
Walnut Creek, CA
Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results
A Long-term, Multi-centre, International, Randomised Double-blind, Placebo-controlled Trial to Determine Liraglutide Effects on Cardiovascular Events
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
2084
mi
from 43215
Walnut Creek, CA
Click here to add this to my saved trials